MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaut.2022.102941

Медицинская библиотека · Journal of autoimmunity · 2022

Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease.

Bay Pierre, de Chambrun Marc Pineton, Rothstein Vincent, Mahevas Matthieu, De Prost Nicolas, Roux Antoine, Zuber Benjamin, Biet Dominique Israël, Hervier Baptiste, Tazi Abdellatif, Mouthon Luc, Mekinian Arsène, Deligny Christophe, Borie Raphaël, Meurice Jean Claude, Meyer Alain, Priou Pascaline, Savale Laurent, De Saint Martin Luc, Gallay Laure, Cottin Vincent, Blanchard Elodie, Brillet Pierre-Yves, Khafagy Philippe, Benveniste Olivier, Nunes Hilario, Allenbach Yves, Uzunhan Yurdagül

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Rapidly progressive interstitial lung disease (RP-ILD) is a frequent and severe manifestation of anti-MDA5 dermatomyositis (MDA5-DM) associated with poor outcome. The optimal treatment regimen for MDA5-DM RP-ILD is yet to be determined. Specifically, the value of adding plasma exchange (PLEX) to corticosteroids and immunosuppressants remains unclear. We aimed to evaluate the effect of PLEX on the outcome of patients with MDA5-DM RP-ILD.

METHODS

This French nationwide multicentre retrospective study included all MDA5-DM RP-ILD patients from 2012 to 2021 admitted to 18 centres. The primary endpoint was one-year transplant-free survival.

RESULTS

51 patients with MDA5-DM RP-ILD (female 67%; mean age at disease onset: 51 ± 11.6 years) were included. Thirty-two (63%) patients required mechanical ventilation and twenty-five (49%) received PLEX. One-year mortality or lung transplant occurred in 63% cases after a median follow-up of 77 [38-264] days. The Cox proportional hazards multivariable model only retained mechanical ventilation but not PLEX (p = 0.7) as independent predictor of the primary endpoint. One-year transplant-free survival rates in PLEX + vs. PLEX-were 20% vs. 54% (p = 0.01), respectively. The Kaplan-Meier estimated probabilities of one-year transplant-free survival was statistically higher in PLEX-compared to PLEX + patients (p = 0.05). PLEX + compared to PLEX-patients more frequently received mechanical ventilation and immunosuppressants suggesting PLEX + patients had a more severe disease.

CONCLUSION

MDA5-DM RP-ILD is associated with poor rate of one-year transplant-free survival. The use of PLEX was not associated with a better outcome albeit they were mainly given to more severe patients. While our study reports the largest series of MDA5-DM RP-ILD given PLEX, these results needs to be interpreted with caution owing the numerous selection, indication and interpretation bias. Further studies are needed to evaluate their efficacy in this setting.

Для цитирования: Bay Pierre, de Chambrun Marc Pineton, Rothstein Vincent, Mahevas Matthieu, De Prost Nicolas, Roux Antoine, Zuber Benjamin, Biet Dominique Israël, Hervier Baptiste, Tazi Abdellatif, Mouthon Luc, Mekinian Arsène, Deligny Christophe, Borie Raphaël, Meurice Jean Claude, Meyer Alain, Priou Pascaline, Savale Laurent, De Saint Martin Luc, Gallay Laure, Cottin Vincent, Blanchard Elodie, Brillet Pierre-Yves, Khafagy Philippe, Benveniste Olivier, Nunes Hilario, Allenbach Yves, Uzunhan Yurdagül. Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease.. Journal of autoimmunity. 2022. DOI: 10.1016/j.jaut.2022.102941.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.